We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Postoperative Pain Reliever

By HospiMedica staff writers
Posted on 18 Jun 2003
A sustained-release injectible drug is designed to provide local analgesia for up to three days, which coincides with the greatest need for postsurgical pain control in most patients.

The postoperative pain relief depot product, developed by Durect Corp. More...
(Cupertino, CA, USA), uses the company's Saber delivery system and a local anesthetic to administer the drug locally around a surgical site following surgery. The active agent is bupivacaine. One dose of the pain relief product is intended to provide up to 72 hours of regional pain relief, compared to conventional practices, which include both opioid and nonopioid medications. A clinical trial on the system has begun.

"This product could potentially reduce hospital stays and the amount of traditional postsurgical pain medications needed by patients, as well as the associated side effects resulting from the use of concomitant opioid medications,” said James E. Brown, president and CEO of Durect.

Durect's patented Saber drug delivery system is a biodegradable, controlled-release technology that can be formulated for parenteral, oral, dermal, or other route of administration of active agents for human pharmaceutical and veterinary applications.




Related Links:
Durect

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.